Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway
Anticancer Research · 2026
DOI: 10.21873/anticanres.17982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Hong-Beum Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Premedical Course, Chosun University School of Medicine, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Nuclear Proteins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Premedical Course, Chosun University School of Medicine, Gwangju, Republic of Korea.
- Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea.
- Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea sgpark@chosun.ac.kr.
Zitieren
APA
Kim, H. B., Lee, H. J., & Park, S. G. (2026). Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway. Anticancer Research. https://doi.org/10.21873/anticanres.17982
Vancouver
Kim HB, Lee HJ, Park SG. Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway. Anticancer Research. 2026. doi:10.21873/anticanres.17982
BibTeX
@article{Kim2026,
author = {Kim, Hong-Beum and Lee, Hee-Jeong and Park, Sang-Gon},
title = {Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.17982}
}
EUVIMED